draws upon the expertise of researchers from both the College Park and Baltimore campuses to create new mechanisms for scientific exchange, education and training, and regulatory science research in order to meet the needs for these new tools.
Building upon her spectacular success with the creation of the Department of Bioengineering and Therapeutic Sciences with past co-chair Sarah Nelson, PhD, Kathy s contributions to CERSI
will be equally distinguished in the coming years, Guglielmo said.
Working closely with FDA scientists, CERSI
researchers will assist the FDA in driving innovation in medical product development as well as in advancing laboratory, population, behavioral, and manufacturing sciences.